fluorodeoxyglucose f18 has been researched along with Adrenal Cortex Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Groussin, L; Jazeron, JF; Libé, R; Louiset, E | 1 |
| Bandelin, PB; Lemar, HJ; Moreno, AJ; Oliver, TG; Stratakis, CA | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Adrenal Cortex Diseases
| Article | Year |
|---|---|
18F-FDG PET reveals an adrenocortical carcinoma in a bilateral adrenal multinodular disease.
Topics: Adrenal Cortex Diseases; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2019 |
The use of positron emission tomography-computed tomography scan in the evaluation of a patient with Carney complex.
Topics: Adrenal Cortex Diseases; Adult; Female; Fluorodeoxyglucose F18; Humans; Hyperpigmentation; Multiple Endocrine Neoplasia; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |